Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Initiative to Maximize Progress in Adolescent and Young Adult Cancer Therapy (IMPACT)
FY 2013-14
Summary
Rationale: Each year, over 2300 Canadians aged 15-29 years are diagnosed with cancer(1); 300 of these patients succumb to their disease.(2) Adolescents and young adults (AYA) with cancer have experienced slower improvements in their chance of survival compared to children or older adults.(3) There has been little research in Canada to explore what factors influence cancer survival in adolescents. It is thought that factors, such as poorer adherence to medications, increased side effects and complications of treatment, may influence AYA survival rates.(4-6) In addition, the location where AYA receive their treatment (a paediatric hospital, an adult cancer centre or a community hospital) may also affect survival. This may because each treatment centre has different levels of expertise in AYA cancer types and their treatment as well as resources dedicated to AYA.
Objectives: This study will examine the impact of treatment location on the survival of AYA patients.
Methods: In order to meet our objective, we will create a database of all adolescents (aged 15-21 years) diagnosed and treated with leukemias, lymphomas, sarcomas and testicular cancer treated in all paediatric and adult hospitals in Ontario between 1992 and 2011. This study has been approved by the research ethic board at all participating treatment centres. Information about AYA’s cancer diagnosis and treatment will be gathered from various existing databases within Ontario. Information that is not available in these databases will be collecting patient charts by done by trained research staff. We will describe disease characteristic of adolescents treated at paediatric versus adult centres and determine whether adolescents treated at paediatric hospitals have a different probability of survival than adolescents treated at adult hospitals. In addition, we will examine the factors that influence the treatment location for adolescents. These factors may include the specialty of AYA’s primary physician (eg family physician, paediatrician) or the distance from their home to a paediatric centre or regional cancer centre.
Relevance to Cancer: Our study will create a unique data set of all adolescents treated for cancer in Ontario over a 19-year period that can be used to address numerous questions regarding adolescent cancer care and outcomes. The results of this study will determine in patients treated at different types of treatment centres have different chances of survival. These findings will have significant implications for policymakers concerned with optimizing outcomes for young Canadians with cancer.
References
1.Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2013. Toronto, ON: Canadian Cancer Society; 2013.
2. Government of Canada. Statistics Canada. 2013; http://www5.statcan.gc.ca/cansim/a26;jsessionid=38715DC084C7190FDAD568EF306A6807. Accessed Aug 13, 2013.
3. Bleyer A, Budd T, Montello M. Adolescents and young adults with cancer: The scope of the problem and practicality of clinical trials. Cancer 2006;7.Suppl:1645-55.
4. Gupta AA,Anderson JR,Pappo AS,Spunt SL,Dasgupta R,Indelicato DJ, Hawkins DS. Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Cancer. 2012;118(4):1130-1137.
5.Patel B,Richards SM,Rowe JM,Goldstone AH, Fielding AK. High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: A UKALL XII analysis.Leukemia.2008;22(308 12).
6. McNeer JL, Raetz EA. Acute lymphoblastic leukemia in young adults: which treatment? Curr Opin Oncol. 2012;24(5):487-494.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
311793
Name
Rayar Meera
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Initiative to Maximize Progress in Adolescent and Young Adult Cancer Therapy (IMPACT)
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adolescent And Young Adults; Cancer; Health Service Results; Treatment Location
Abstract
Rationale: Each year, over 2300 Canadians aged 15-29 years are diagnosed with cancer(1); 300 of these patients succumb to their disease.(2) Adolescents and young adults (AYA) with cancer have experienced slower improvements in their chance of survival compared to children or older adults.(3) There has been little research in Canada to explore what factors influence cancer survival in adolescents. It is thought that factors, such as poorer adherence to medications, increased side effects and complications of treatment, may influence AYA survival rates.(4-6) In addition, the location where AYA receive their treatment (a paediatric hospital, an adult cancer centre or a community hospital) may also affect survival. This may because each treatment centre has different levels of expertise in AYA cancer types and their treatment as well as resources dedicated to AYA.
Objectives: This study will examine the impact of treatment location on the survival of AYA patients.
Methods: In order to meet our objective, we will create a database of all adolescents (aged 15-21 years) diagnosed and treated with leukemias, lymphomas, sarcomas and testicular cancer treated in all paediatric and adult hospitals in Ontario between 1992 and 2011. This study has been approved by the research ethic board at all participating treatment centres. Information about AYA’s cancer diagnosis and treatment will be gathered from various existing databases within Ontario. Information that is not available in these databases will be collecting patient charts by done by trained research staff. We will describe disease characteristic of adolescents treated at paediatric versus adult centres and determine whether adolescents treated at paediatric hospitals have a different probability of survival than adolescents treated at adult hospitals. In addition, we will examine the factors that influence the treatment location for adolescents. These factors may include the specialty of AYA’s primary physician (eg family physician, paediatrician) or the distance from their home to a paediatric centre or regional cancer centre.
Relevance to Cancer: Our study will create a unique data set of all adolescents treated for cancer in Ontario over a 19-year period that can be used to address numerous questions regarding adolescent cancer care and outcomes. The results of this study will determine in patients treated at different types of treatment centres have different chances of survival. These findings will have significant implications for policymakers concerned with optimizing outcomes for young Canadians with cancer.
References
1.Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2013. Toronto, ON: Canadian Cancer Society; 2013.
2. Government of Canada. Statistics Canada. 2013; http://www5.statcan.gc.ca/cansim/a26;jsessionid=38715DC084C7190FDAD568EF306A6807. Accessed Aug 13, 2013.
3. Bleyer A, Budd T, Montello M. Adolescents and young adults with cancer: The scope of the problem and practicality of clinical trials. Cancer 2006;7.Suppl:1645-55.
4. Gupta AA,Anderson JR,Pappo AS,Spunt SL,Dasgupta R,Indelicato DJ, Hawkins DS. Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Cancer. 2012;118(4):1130-1137.
5.Patel B,Richards SM,Rowe JM,Goldstone AH, Fielding AK. High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: A UKALL XII analysis.Leukemia.2008;22(308 12).
6. McNeer JL, Raetz EA. Acute lymphoblastic leukemia in young adults: which treatment? Curr Opin Oncol. 2012;24(5):487-494.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Rayar, Meera
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~